September 11, 2018 | Dory Benford
Johnny Lopez's research into the latest prostate cancer treatments, clinical trials, experimental therapies — anything to avoid chemotherapy, and a recommendation from a friend also battling prostate cancer, led him to Tanya Dorff, M.D., and City of Hope.
New hormone and immunotherapy trial for breast cancer patients
October 8, 2019 | City of Hope
This phase 2 trial studies the side effects and how well pembrolizumab and enobosarm work in treating patients with androgen receptor positive triple-negative breast cancer that has spread to other places in the body.
Researchers identify new target for potential type 1 diabetes treatment
October 18, 2018 | Katie Neith
Recently a team of researchers led by City of Hope scientists identified a new potential target to keep the immune system stable and islet beta cells healthy, in an effort to keep type 1 diabetes at bay.
A triple-negative breast cancer trial has its first success story
October 12, 2018 | Maxine Nunes
Linda Collins's outlook was bleak, thanks to her triple-negative breast cancer diagnosis, until City of Hope oncologist Yuan Yuan, M.D., Ph.D. helped develop a revolutionary new trial to help her.
Crime fighters fight breast cancer with the Pink Patch Project
October 11, 2018 | Maxine Nunes
San Bernardino District Attorney Child Abduction Unit investigative tech and City of Hope breast cancer survivor Michelle Faxon and her law enforcement colleagues are involved with the Pink Patch Project to raise funds for breast cancer research.
Patients over 60 needed for HER2-positive breast cancer study
October 7, 2018 | City of Hope
Researchers are actively recruiting for patients 60 years and older for a phase 2 trial studying the side effects of and how well neratinib works in treating older patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer that has spread from where it started to other places in the body.
Core Connection: Comprehensive Metabolic Phenotyping Core
October 4, 2018 | Katie Neith
As both genetics and environmental stimuli can have an effect on the progression of illnesses and on the efficacy of treatments, one particularly important area of study is metabolism, which lies at the intersection of many diseases.
CIRM Awards City of Hope Researchers $3.7 million to Develop Glioblastoma Clinical Trial
September 28, 2018 | Letisia Marquez
California Institute for Regenerative Medicine has awarded City of Hope $3.7 million to develop a phase 1 clinical trial for glioblastoma patients, which would genetically alter blood stem cells to better tolerate chemotherapy.
CAR T researcher Saul Priceman wants to teach your body to fight cancer
September 13, 2018 | Letisia Marquez
Since 2013, City of Hope researcher Saul Priceman, Ph.D., and his team have developed one of most comprehensive CAR T programs in the nation.
The Wanek Family Project to Cure Type 1 Diabetes: 18 months later
August 9, 2018 | Dory Benford
Last year, the City of Hope Wanek Family Project to Cure Type 1 Diabetes launched 16 projects across multiple disciplines, including immunology, endocrinology, cellular therapeutics, nutrition and metabolism. Now, 18 months in, we are pleased with our progress and more optimistic than ever about finding a cure.